![]() | SII's free supply of Covishield to Centre: First lot of 80 lakh doses set for dispatchSince the launch of the anti-Covid vaccination drive, SII has so far provided 170 crore doses of Covishield to the government. |
![]() | COVID-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar PoonawallaCovovax works very well against omicron variant,more than Covishield, says Adar Poonawalla. |
![]() | Posing as Adar Poonawalla, scammers dupe SII of Rs 1 cr; 7 nabbedA complaint in this regard was registered and during the investigation, police zeroed in on the eight accounts to which the money was transferred. |
![]() | SII stopped Covishield production in Dec 2021; Poonawalla; claims are no takers for booster shotsThe SII had announced its partnership with Oxford University to manufacture the vaccine in April 2020. |
![]() | Fraudsters dupe Serum Institute of Rs 1 crore by asking for money transfer in CEO's nameThe fraud unfolded between the afternoons of Wednesday and Thursday, said an official of Bundgarden police station. |
![]() | Bombay HC issues notice to Central govt, Serum Institute over plea on alleged Covid vaccine deathDilip Lunawat in his petition blamed the authorities for creating alleged false narratives and misrepresentations about the Coronavirus vaccine. |
![]() | India's first vaccine against cervical cancer to launch on September 1The most awaited vaccine will be launched by the Union Minister of State (Independent Charge) Science & Technology Jitendra Singh on September 1. |
![]() | Odisha to introduce HPV vax in 10 aspirational districts in the first phaseThe State government has also decided to expand screening and services for breast and cervical cancers from medical colleges to the district headquarters hospital (DHH). |
![]() | Drug controller allows sale of Serum Institute’s cervical cancer vaccineThe DCGI’s approval came following a recommendation by the Subject Expert Committee (SEC) on Covid-19 of the CDSCO on June 15. |
![]() | Panel for emergency use approval to SII vaccination for 7-11 age groupOfficials said the Subject Expert Committee deliberated upon the matter and recommended EUA for use in younger children. |
![]() | Government panel recommends market authorisation for SII's qHPV vaccine against cervical cancerIn the application, Singh is learnt to have stated that qHPV vaccine CERVAVAC has demonstrated robust antibody response that is nearly 1,000 times higher than the baseline. |
![]() | Serum Institute, Symbiosis to set up research centre for vaccine developmentThe entity will work towards improving health equity against future pandemics and infectious diseases. It will also ensure cross-programme coordination and collaboration. |
![]() | Millions of COVID vaccines unsold; stopped production since December 2021: Adar PoonawallaHe also called for speeding up the decision to vaccinate young kids and said if they can be given other immunisation vaccines why not for the COVID-19. |
![]() | Poonawalla warns against return to business-as-usual approachCalling for increased adoption of booster doses, Poonawalla said it is also needed because people need to travel internally and outside, many countries have made booster doses mandatory for travel. |
![]() | Panel seeks more data on Serum Institute's EUA application for Covovax useThe SII had last month submitted an application to the Drugs Controller General of India (DCGI) seeking emergency use authorisation (EUA) for Covovax's use among children in the age group. |
![]() | Covishield & Covaxin prices cut, hospitals to pay Rs 225 per doseThe precautionary dose has to be of the same vaccine used for the first two doses. |
![]() | Serum Institute, Bharat Biotech cut COVID vaccine prices for private hospitals to Rs 225The Union Health Ministry on Friday announced that those above the age of 18 years who have completed nine months after the administration of the second dose will be eligible for the precaution dose. |
![]() | Serum Institute's Covishield precaution dose priced at Rs 600 per shotThe Union Health Ministry on Friday announced that those above the age of 18 years who have completed nine months after the administration of the second dose will be eligible for the precaution dose. |
![]() | Low number of COVID-19 cases now as India chose right vaccine, says PoonawallaSpeaking to reporters on the sidelines of the 'Alternate Fuel Conclave', he said the fourth wave, if at all it occurs, will hopefully be mild. |
![]() | SC reserves verdict on plea seeking data on clinical trials of vaccination drivesA petition filed by a former member of the National Technical Advisory Group on Immunisation (NTAGI) Jacob Puliyel sought disclosure of post-vaccination data and clinical trial data. |
Latest
Delhi Police detains 24 DU students for planning to screen BBC documentary on Modi
Gautam Adani slips to 7th spot on the world rich list; net worth declines by over USD 22 billion
India wins toss, opts to bowl against New Zealand in 1st T20I
Suryakumar a trailblazer, will bring about global revolution in T20 cricket: Ponting
Veteran actress Jamuna dies at 86
#AngryRanbirKapoor trends as video of actor tossing fan's phone goes viral